Teleflex(TFX)

Search documents
Teleflex(TFX) - 2024 Q1 - Quarterly Results
2024-05-02 11:00
Exhibit 99.1 FOR IMMEDIATE RELEASE May 2, 2024 Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook Wayne, PA -- Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the first quarter ended March 31, 2024. First quarter financial summary 1 • Revenues of $737.8 million, up 3.8% compared to the prior year period; up 3.8% on a constant currency basis • GAAP diluted EPS from continuing operations of $0.33, compared to $1.63 in the prior year period • Adj ...
Teleflex(TFX) - 2023 Q4 - Annual Report
2024-02-23 17:23
Financial Performance - Net revenues for 2023 were $2,974.5 million, up from $2,791.0 million in 2022[340] - Gross profit increased to $1,646.9 million in 2023 from $1,531.1 million in 2022[340] - Net income for 2023 was $356.3 million, compared to $363.1 million in 2022 and $485.4 million in 2021[343] - Comprehensive income for 2023 was $445.4 million, up from $306.6 million in 2022 and $435.7 million in 2021[343] - Net cash provided by operating activities from continuing operations increased to $511.7 million in 2023, up from $342.8 million in 2022[242] - Free cash flow rose to $420.2 million in 2023, compared to $263.6 million in 2022[242] - Net cash provided by financing activities from continuing operations was $38.5 million in 2023, primarily due to $101.3 million in net proceeds from borrowings for the acquisition of Palette[239] - Net revenues for the year ended December 31, 2023, were $2,974.5 million, compared to $2,791.0 million in 2022 and $2,809.6 million in 2021[386] International Operations - 72% of the company's full-time employees were employed outside the U.S., and 58% of net property, plant, and equipment was located outside the U.S. as of December 31, 2023[127] - 37% of net revenues for 2023 were derived from operations outside the U.S.[127] - Asia net revenues for 2023 increased by $40.6 million (13.2%), driven by a $25.5 million increase in sales volume of existing products and an $18.8 million increase in sales of new products[220] - Asia operating profit for 2023 increased by $7.3 million (8.8%), primarily due to higher sales[221] - Cash and cash equivalents as of December 31, 2023, totaled $222.8 million, with $196.7 million held at non-U.S. subsidiaries[227] Acquisitions and Contingent Liabilities - Contingent consideration liabilities as of December 31, 2023, amounted to $39.5 million, primarily related to acquisitions of Standard Bariatrics Inc. and Palette[121] - The company completed the acquisition of Palette on October 10, 2023, with a fair value of consideration transferred of $621.9 million[335] - Identifiable intangible assets acquired in the Palette acquisition included $264.0 million in intellectual property and $40.5 million in trade names intangible assets[335] - The company completed the acquisition of Palette Life Sciences AB for $621.9 million, including $594.9 million in net cash payments and $27.0 million in contingent consideration[388] - The Palette acquisition added $333.5 million in intangible assets and $357.0 million in goodwill[390] - The fair value of contingent consideration liabilities was $39.5 million as of December 31, 2023[461] - Contingent consideration liabilities decreased from $44.0 million at the beginning of 2023 to $39.5 million by the end of 2023, primarily due to revaluations and adjustments[472] - The maximum potential payment under contingent consideration arrangements related to acquisitions is $177.0 million[468] - Revenue volatility for contingent consideration liabilities ranges from 15.1% to 20.3%, with a weighted average of 18.8%[470] Segment Performance - OEM net revenues for 2023 increased by $53.4 million (19.6%), driven by a $28.3 million increase in sales volume of existing products and price increases[222] - OEM operating profit for 2023 increased by $20.8 million (31.9%), primarily due to price increases and higher sales[223] - The OEM segment revenue increased to $326.0 million in 2023 from $272.6 million in 2022[386] - The Vascular Access product category generated $708.0 million in revenue for 2023, up from $683.6 million in 2022[386] Balance Sheet and Cash Flow - Total assets increased to $7.53 billion in 2023 from $6.93 billion in 2022, driven by growth in goodwill and intangible assets[346] - Goodwill increased to $2.91 billion in 2023 from $2.54 billion in 2022, reflecting acquisitions and business combinations[346] - Retained earnings grew to $4.11 billion in 2023 from $3.82 billion in 2022, supported by net income generation[349] - Cash and cash equivalents decreased to $222.8 million in 2023 from $292.0 million in 2022, reflecting cash usage for operations and investments[346] - Total liabilities increased to $3.09 billion in 2023 from $2.91 billion in 2022, primarily due to higher long-term borrowings[346] - The company had $262.0 million in borrowings outstanding and $0.9 million in outstanding standby letters of credit under its $1.0 billion revolving credit facility as of December 31, 2023[245] - The company borrowed the maximum amount available of $75 million under its accounts receivable securitization facility as of December 31, 2023[248] Risk Management and Derivatives - The company entered into a zero-cost foreign exchange collar contract in December 2023 to manage foreign exchange risk related to $500 million notional cross-currency swaps[229] - A 1.0% change in variable interest rates would impact annual interest expense by $8.2 million based on outstanding debt as of December 31, 2023[279] - Derivative assets valued at $63.6 million and derivative liabilities at $1.5 million, both classified under Level 2 of the fair value hierarchy[463] Shareholder Equity and Shares - Basic weighted average shares outstanding for 2023 were 46.98 million, with a dilutive effect of 0.32 million shares from share-based awards, resulting in diluted shares of 47.30 million[474] - The company has 200 million authorized common shares and 500,000 preference shares, with no preference shares outstanding in the last three years[473] Reserves and Allowances - The liability for returns and allowances was $22.2 million as of December 31, 2023, up from $17.9 million in 2022[379] - The reserve for customer incentive programs, including rebates, was $26.7 million as of December 31, 2023, down from $29.0 million in 2022[379] Investments and Fair Value - Investments in marketable securities valued at $10.1 million as of December 31, 2022, classified under Level 1 of the fair value hierarchy[463] - Contingent consideration liabilities valued at $44.0 million as of December 31, 2022, classified under Level 3 of the fair value hierarchy[463] Transaction Expenses - The company incurred $10.6 million in transaction expenses related to the Palette acquisition[391] Goodwill and Impairment - The company did not record any goodwill impairment charges for the year ended December 31, 2023[360] Revenue Sources - The company's revenue from hospitals and healthcare providers represented 87% of consolidated net revenues for the year ended December 31, 2023[377] Obligor Group Performance - Obligor Group net revenue for 2023 was $2,128.2 million, with gross profit of $764.9 million and net income of $259.5 million[233]
Teleflex(TFX) - 2023 Q4 - Earnings Call Transcript
2024-02-22 17:11
Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Conference Call February 22, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President of Investor Relations and Strategy Development Liam Kelly - Chairman, President and CEO Thomas Powell - Executive Vice President and CFO Conference Call Participants Patrick Wood - Morgan Stanley Jayson Bedford - Raymond James Shagun Singh - RBC Capital Markets Michael Sarcone - Jefferies Larry Biegelsen - Wells Fargo Matthew O'Brien - Piper Sandler Mike ...
Teleflex(TFX) - 2023 Q4 - Annual Results
2024-02-22 12:00
Exhibit 99.1 FOR IMMEDIATE RELEASE February 22, 2024 Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results Wayne, PA -- Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the fourth quarter ended December 31, 2023. Fourth quarter financial summary Full year 2023 financial summary 2024 guidance summary "We demonstrated solid execution during the fourth quarter against a stable to improving macro-environment," said Liam Kelly, Teleflex's Chairman, President ...
Teleflex(TFX) - 2023 Q3 - Earnings Call Transcript
2023-11-06 04:50
Teleflex Incorporated (NYSE:TFX) Q3 2023 Earnings Conference Call November 2, 2023 8:00 AM ET Company Participants Lawrence Keusch - Vice President of Investor Relations and Strategy Development Liam Kelly - Chairman, President and Chief Executive Officer Thomas Powell - Executive Vice President and Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Jayson Bedford - Raymond James Shagun Singh - RBC Mike Sarcone - Jefferies Vik Chopra - Wells Fargo George Sellers - Stephens In ...
Teleflex(TFX) - 2023 Q3 - Earnings Call Presentation
2023-11-04 12:03
| --- | --- | --- | |---------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | Teleflex Incorporated Third Quarter 2023 Earnings Conference Call | | | The release, accompanying slides, and replay webcast are available online at www.teleflex.com (click on Investors) The confirmation code is 87648. Liam Kelly Chairman, President and CEO Tfeleflex® Note on Forward-Looking Statements Conference Call Logistics The call can be accessed by dialing 1 800 770 20 ...
Teleflex(TFX) - 2023 Q2 - Earnings Call Presentation
2023-08-03 19:56
| --- | --- | --- | |----------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | Teleflex Incorporated Second Quarter 2023 Earnings Conference Call | | | The release, accompanying slides, and replay webcast are available online at www.teleflex.com (click on Investors) 2 Conference Call Logistics The call can be accessed by dialing 1 800 770 2030 (U.S.) or 1 647 362 9199 (all other locations). Today's Speakers Thomas Powell Executive VP and CFO Tfeleflex® ...
Teleflex(TFX) - 2023 Q2 - Earnings Call Transcript
2023-08-03 15:58
Lawrence Keusch - VP, IR & Strategy Development Liam Kelly - Chairman, President & CEO Thomas Powell - EVP & CFO Operator Lawrence Keusch Before we begin, I'd like to remind you that some of the matters discussed in this conference call will contain forward-looking statements regarding future events as outlined in the slides posted to the Investor Relations section of the Teleflex website. We wish to caution you that such statements are, in fact, forward-looking in nature and are subject to risks and uncert ...
Teleflex(TFX) - 2023 Q1 - Earnings Call Transcript
2023-05-06 23:27
The overseas launch activity in Japan and China are progressing in line with expectations. OEM revenues increased 34.5% year-over-year to $77 million. The strength in the quarter was broad-based across our portfolio with double-digit growth in all product categories. We continue to have good visibility into the business and see solid demand dynamics throughout 2023. First quarter other revenue increased 6.4% to $71.6 million year-overyear. We continue to expect all MSA revenues to cease at the end of 2023, ...
Teleflex(TFX) - 2023 Q1 - Earnings Call Presentation
2023-05-06 18:22
Note: See appendices for reconciliations of non-GAAP financial information. Solid start to the year keeps us well-positioned to deliver on our financial guidance for 2023 Thank You 15 16 Non-GAAP Financial Measures 18 Intangible amortization expense - Certain intangible assets, including customer relationships, intellectual property, distribution rights, trade names and non-competition agreements, initially are recorded at historical cost and then amortized over their respective estimated useful lives. The ...